Scholarlink

Background <p>Diabetes mellitus (DM), a leading non-communicable disease, necessitates cost-effective, safer alternatives, particularly in India where traditional medicine predominates. This study evaluated a compound Unani formulation (CUF) for antidiabetic potential using the oral glucose tolerance test (OGTT) in euglycemic rats and nicotinamide-streptozotocin-induced NIDDM model in Wistar rats.</p> Results <p>CUF significantly attenuated glucose excursion during OGTT in euglycemic rats for up to 60&#xa0;min across both dose levels. In the NIDDM model, CUF produced marked reductions in fasting blood glucose on days 14 and 28 of treatment. The formulation exhibited robust antioxidant activity, with results corroborating its traditional ethnopharmacological application in diabetes management.</p> Conclusion <p>CUF demonstrated significant antihyperglycemic effects in OGTT (euglycemic rats) and NIDDM models, alongside robust antioxidant activity, validating its traditional ethnopharmacological use for diabetes management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring the anti-diabetic effects of a complementary formulation in rats with nicotinamide-streptozotocin-induced diabetes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月11日

查看全文
  • Mohd Anas,
  • Gulam Mohammed Husain,
  • Tasleem Ahmad,
  • Uzma Viquar,
  • Mohammed Abdul Rasheed Naikodi,
  • Ghali Shravan Kumar,
  • Younis Iftikhar Munshi,
  • Noor Zaheer Ahmed,
  • Mohammad Zakir

摘要

Background

Diabetes mellitus (DM), a leading non-communicable disease, necessitates cost-effective, safer alternatives, particularly in India where traditional medicine predominates. This study evaluated a compound Unani formulation (CUF) for antidiabetic potential using the oral glucose tolerance test (OGTT) in euglycemic rats and nicotinamide-streptozotocin-induced NIDDM model in Wistar rats.

Results

CUF significantly attenuated glucose excursion during OGTT in euglycemic rats for up to 60 min across both dose levels. In the NIDDM model, CUF produced marked reductions in fasting blood glucose on days 14 and 28 of treatment. The formulation exhibited robust antioxidant activity, with results corroborating its traditional ethnopharmacological application in diabetes management.

Conclusion

CUF demonstrated significant antihyperglycemic effects in OGTT (euglycemic rats) and NIDDM models, alongside robust antioxidant activity, validating its traditional ethnopharmacological use for diabetes management.